Additional Resources for Clinicians, Researchers, and Healthcare Professionals
We would like to announce a clinical trial study for high risk naïve, relapsed or refractory Myelodysplastic Syndrome (MDS) patients. + Read More
Would you like your treatment center to become part of the referral system for MDS patients and be designated as a Center of Excellence? To be recognized as a Center of Excellence, an institution must have:+ Read More
touchONCOLOGY and touchHAEMATOLOGY are proud to be at the forefront of on-demand and virtual formats, pushing the boundaries for online medical education. + Read More
Developed by the International Working Group for the Prognosis of MDS (IWG-PM) under the aegis of the MDS Foundation, Inc.+ Read More